Scope
The AAP guideline covers urinary tract infection in children from 8 days through 5 years. Its official author-written clinical summary describes changes to risk assessment, diagnostic criteria, antibiotic exposure, imaging and recurrent-infection care. It replaces the narrower age scope of the retired guidance. This House summary follows the decision points actually described in that article; it does not reconstruct the full guideline’s age-specific urine-test thresholds, treatment durations or referral algorithms.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Population and risk assessment
- Apply this guideline to infants and children aged 8 days through 5 years. Its scope extends beyond the retired guideline’s febrile 2–24-month population. [1]
- Base risk assessment on clinical findings and individual characteristics. Race is excluded from the recommendations and should not be used as a biological predictor of UTI risk. [1]
Distinguish infection from asymptomatic bacteriuria
- Interpret culture together with the guideline’s age- and collection-method-specific leukocyte esterase and urine white-cell criteria when deciding on empiric treatment or confirming infection. Distinguishing infection from asymptomatic bacteriuria is a central aim. [1]
- The stated catheterized-specimen culture threshold is reduced to 10,000 colony-forming units/mL from 50,000. This is a catheter-specimen criterion within the broader diagnostic framework, not a stand-alone definition for every specimen type. [1]
Tailor antibiotic duration
- Use the age- and severity-based treatment approach. Uncomplicated cystitis may permit a shorter course; younger infants, pyelonephritis and other higher-risk presentations may require longer therapy. The article supports avoiding unnecessary exposure while adequately treating infection. [1]
Select imaging and specialist review
- Renal and bladder ultrasound is primarily used to identify structural abnormalities predisposing to recurrence or kidney injury; it performs poorly as a screening test for vesicoureteral reflux. [1]
- A routine voiding cystourethrogram is unnecessary after a first febrile UTI in a low-risk child. The guideline supports selective use and describes circumstances for earlier testing. [1]
- Arrange subspecialist referral for abnormal imaging and vesicoureteral reflux. For children with reflux, use a risk-based approach to prophylaxis and shared decisions with families, reserving prophylaxis primarily for those at greater risk of recurrence or renal injury. [1]
Address bowel and bladder contributors
- Routinely assess for constipation, dysfunctional voiding and other bladder–bowel dysfunction when evaluating a child with UTI. Addressing these contributors may reduce recurrent infection and repeated treatment or investigation. [1]
Limitations and use
- This summary is based on the AAP News article by the guideline panel chair and vice-chair, not the complete guideline and technical reports.
- The article does not provide the exact age-specific leukocyte esterase or pyuria thresholds, antibiotic agents, doses or durations, or the full criteria for earlier cystourethrography and referral. The catheter-culture threshold alone is insufficient to establish infection.
- The age range is 8 days through 5 years; this source does not establish a pathway for younger neonates or older children.
- This House summary is based on the linked focused or condensed recommendation sources; it does not represent the complete original publication.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Urinary tract infection in children aged 8 days to 5 years — focused recommendation source
Selected recommendation material consulted
Publication details
- Issuing organisation
- AAP
- First published
- 28 September 2026
- Resource type
- Clinical practice guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.